Plain-English translation of NCT06698458 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new treatment called Alpha DaRT—tiny radioactive seeds that are placed directly into a pancreatic tumor—combined with standard chemotherapy drugs. The study wants to see if this combination is safe and helps people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body. You would receive chemotherapy first, then the seeds would be implanted during the early treatment cycles.
Pancreatic cancer is very difficult to treat, especially when surgery is not an option. Doctors are looking for new ways to deliver radiation directly to the tumor while also using chemotherapy, hoping this combination will work better than chemotherapy alone.
You would start chemotherapy first, then during your first 4 cycles of chemotherapy, you would undergo a procedure to have the radioactive seeds implanted directly into your tumor. This requires a specialized placement procedure, likely guided by imaging. You would then continue with your regular chemotherapy and follow-up visits. The study team would monitor you for 6 months after you enroll to check how well the treatment works and watch for any side effects.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States